In re Biovail Corporation Securities Litigation
|Court:||United States District Court, Southern District of New York|
|Judge:||Hon. Gerald E. Lynch|
|Class Period:||02/07/2003 - 03/02/2004|
|Case Contacts:||Katherine M. Sinderson|
This is a securities fraud class action filed on behalf of all investors who purchased the common stock of Biovail Corporation ("Biovail" or the "Company") between February 7, 2003 and March 2, 2004 (the "Class Period"). Defendants include the Company and certain of its former senior officers and directors, including Eugene N. Melnyk, Biovail's former Chairman and CEO. Biovail is a pharmaceutical company headquartered in Canada, with operations in the United States.
August 8, 2008 — Court Grants Final Approval of $138 Million Settlement
After nearly four years of intensive litigation, Co-Lead Counsel BLB&G and its client, Court-appointed Co-Lead Plaintiff the Ontario Teachers' Pension Plan Board ("OTPP"), announce a settlement agreement of $138 million in cash with Biovail Corporation and certain of its officers. The settlement also provides for the implementation of certain corporate governance enhancements. This is the second largest recovery in a securities case involving a Canadian issuer, second only to Nortel — another case in which OTPP was represented by BLB&G as Co-Lead Plaintiff.
On April 9, 2008, the Court granted preliminary approval to the proposed settlement. Among other things, the Court's Order directed that Notice of the proposed settlement be provided to potential class members.
A settlement fairness hearing was held on August 8, 2008, during which time the Court granted final approval of the settlement. In order to have been eligible to share in the benefits of the settlement, class members should have submitted a completed and signed Proof of Claim and Release form postmarked no later than September 8, 2008.
Other Cases of Interest
Kraft Heinz Company
Northern District of Illinois Salvatore J. Graziano, Katherine M. Sinderson, Abe Alexander, Nicholas Gersh, Kyle Panton
Merck & Co., Inc. (Vioxx-Related)
District of New Jersey Salvatore J. Graziano, Katherine M. Sinderson, David Wales, Adam H. Wierzbowski, Abe Alexander, Catherine E. van Kampen
Salix Pharmaceuticals, Ltd.
Southern District of New York Salvatore J. Graziano, John Rizio-Hamilton, Katherine M. Sinderson, Michael D. Blatchley, Adam Hollander, Alex Dickin, Catherine E. van Kampen
District of Delaware Katherine M. Sinderson, Hannah Ross, Lauren McMillen Ormsbee, Richard D. Gluck, Catherine E. van Kampen, Jesse L. Jensen, Alex Dickin
Spectrum Brands Holdings, Inc.
Western District of Wisconsin Avi Josefson, Katherine M. Sinderson, Jai K. Chandrasekhar, Matthew Traylor, Catherine E. van Kampen
Northern District of Illinois Eastern Division John C. Browne, Gerald H. Silk, Adam Hollander, Abe Alexander, Scott R. Foglietta, James M. Fee, Katherine M. Sinderson, Reiko Cyr
District of New Jersey Salvatore J. Graziano, Katherine M. Sinderson, Adam Hollander, James M. Fee, Emily Strickland, Sandy Yaklin
FleetCor Technologies, Inc.
Northern District of Georgia Katherine M. Sinderson, Scott R. Foglietta, Alex Dickin
Grand Canyon Education, Inc.
District of Delaware Katherine M. Sinderson, Gregory V. Varallo, Robert Kravetz, Michael Mathai, Will Horowitz
Dollar General Corporation Shareholder Litigation
Sixth Circuit Court for Davidson County, Tennessee; Twentieth Judicial District, Nashville Mark Lebovitch, Katherine M. Sinderson